Robert Half International Inc. — Q3 2022 Form 10-Q
Business and period: Robert Half provides contract and permanent-placement talent solutions; Protiviti provides consulting, risk, technology and internal-audit services. This unaudited filing covers the three and nine months ended September 30, 2022, compared with the same 2021 periods.
Financial performance
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Service revenue | $1.833bn | $1.713bn | $5.511bn | $4.692bn |
| Gross margin | $787.6m; 43.0% | $725.3m; 42.4% | $2.375bn; 43.1% | $1.952bn; 41.6% |
| Income before taxes | $225.6m | $227.7m | $693.9m | $581.6m |
| Net income | $166.2m | $170.9m | $510.3m | $430.7m |
| Diluted EPS | $1.53 | $1.53 | $4.65 | $3.85 |
- Q3 revenue increased 7.1% year over year; reported growth was 10.0% in the U.S. and international revenue declined 3.3%. On a currency- and billing-day-adjusted basis, global revenue growth was 10.7% for contract talent solutions, 20.3% for permanent placement and 4.8% for Protiviti.
- Q3 segment revenue: contract talent solutions $1.140bn (+8.1% reported), permanent placement $182.3m (+16.5%), and Protiviti $511.4m (+2.0%). Contract staffing’s higher bill rates were partly offset by fewer hours; Protiviti’s higher rates were offset by lower billable hours and a shift in consultant mix.
- Q3 gross margin percentage rose 0.6 percentage points. Contract talent solutions margin declined to 39.4% from 40.0%, primarily on higher fringe costs; Protiviti’s reported margin rose to 30.5% from 29.5%.
- Q3 pretax income declined slightly and net income fell 2.7%, despite revenue growth. Pretax margin was 12.3%, versus 13.3%. Management reported higher SG&A as a share of revenue (29.9% versus 28.9%), including higher Protiviti operating expenditures and permanent-placement compensation costs.
- For the first nine months, revenue grew 17.5%, net income grew 18.5%, and diluted EPS grew 20.8%. Adjusted segment revenue growth was 20.4% for contract talent solutions, 41.3% for permanent placement and 11.3% for Protiviti.
Cash, liquidity and capital
- Cash and cash equivalents were $593.3m at September 30, 2022, down from $619.0m at December 31, 2021. Accounts receivable was $1.101bn; current assets were $2.250bn and current liabilities $1.234bn.
- Nine-month operating cash flow was $481.5m, compared with $458.3m in 2021. Investing used $72.2m and financing used $400.4m; financing included $257.8m of share repurchases and $142.6m of dividends paid. Foreign exchange reduced cash by $34.5m.
- The company reported no borrowings under its $100m revolving credit facility, which matures in May 2024, and said it was in compliance with its covenants. Management expects internally generated cash to cover working-capital needs, fixed payments, dividends and other obligations.
- Operating lease liabilities totaled approximately $232.0m, including $81.1m current. The company had $5.7m of additional executed lease commitments not yet commenced. It deferred $51.1m of payroll taxes, expected to be paid within the next 12 months.
- Capital expenditures, including capitalized cloud-computing costs, were $78m for the nine months. Management expected full-year 2022 capital expenditures of $90m–$100m, including $70m–$80m for software and technology infrastructure.
- The company declared a $0.43-per-share quarterly dividend for payment on December 15, 2022. Up to 4.7m additional shares remained authorized for repurchase at September 30.
Outlook, risks and unusual items
- Management said labor demand remained high, but economic uncertainty was lengthening client sales cycles. It cited limited revenue visibility because engagements are generally short-term and demand depends on economic and labor-market conditions. No revenue or earnings guidance was provided.
- The stronger U.S. dollar reduced nine-month reported revenue by $101m, or 2.1%, and net income by $5m, or 1.1%, compared with the prior year. Management said the net-income impact would be immaterial if exchange rates remained at September-end levels for the rest of 2022.
- Investment losses in employee deferred-compensation trusts were $111.0m for the first nine months, versus $38.0m of income in 2021. The related changes in employee obligations offset these investment results, leaving no net cost to the company. The Q3 trust investment loss was $15.3m.
- Two California putative class-action matters allege, respectively, unpaid interview-related compensation and recruiter misclassification and related wage-and-hour violations. The company said outcomes and potential losses could not be reasonably estimated, recorded no provision, and intends to defend the claims. It reported no material developments in previously disclosed legal proceedings.
- Other principal risks include economic weakness, reduced client demand, candidate shortages, competition, margin pressure, foreign exchange, regulation, litigation, cybersecurity and the ability to attract and retain employees. Management reported effective disclosure controls and no material changes to controls during the quarter.
Important facts for investors to verify
- Whether lengthening sales cycles, Protiviti utilization and the Q3 decline in contract staffing hours persist.
- How margins develop as compensation, fringe costs and operating expenses change, particularly in Protiviti and permanent placement.
- The effects of macroeconomic conditions and foreign exchange on reported revenue, earnings and international operations.
- Future working-capital requirements, cash generation, capital spending, share repurchases and dividend sustainability.
- Any developments in the California litigation and the company’s estimated exposure, if it becomes reasonably estimable.